Dept of Health & Social Care – ENGLAND : SHIELDING ADVICE FOR THE CLINICALLY EXTREMELY VULNERABLE TO STOP FROM APRIL. Advice to the clinically extremely vulnerable to shield ceases from Thursday 1 April, as virus infection rates continue to fall People on...
Have you heard our latest podcast episode?
In this latest episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim. CLICK HERE to listen today!
